The New International Staging System Lung Cancer

Size: px
Start display at page:

Download "The New International Staging System Lung Cancer"

Transcription

1 The New International Staging System Lung Cancer Valerie W. Rusch, MD Chief, Thoracic Surgery Memorial Sloan-Kettering Cancer Center Chair, Lung and Esophagus Task Force, American Joint Commission on Cancer Member, IASLC Staging Committee

2 HISTORY OF STAGING TNM Concept Describes extent of tumor: local (T = tumor) regional (N = nodes) distant (M = metastasis) Developed by Pierre Denoix Accepted by UICC in 1953 as basis for classification of anatomical extent of cancer Incorporated in 1 st edition of staging manual, 1968

3 HISTORY OF STAGING: UICC and AJCC From s, variations among staging systems 1987: Reconciliation of AJCC and UICC staging system Currently, AJCC and UICC agree jointly on revisions and publish simultaneously AJCC / UICC staging systems used worldwide and govern all US state and national tumor registries

4 Clifton F. Mountain, Chief, Thoracic Surgery, M.D. Anderson Hospital and Tumor Institute, (Houston, TX)

5 LUNG CANCER STAGING In 1973, AJC proposed TNM staging system for lung cancer Based on 2155 cases in Mountain s database at MDACC Expanded database used by Mountain to propose revisions through 1997 (5 th editions) No data to recommend changes for 6 th editions of staging manuals

6 LUNG CANCER STAGING IASLC* Staging Committee & Database Following 1997 staging system revision, IASLC decided to sponsor development of international database , IASLC database organized by Peter Goldstraw (thoracic surgeon, Brompton, UK) and John Crowley (CRAB, Seattle, USA) IASLC Staging Committee is international and multidisciplinary * = International Association for the Study of Lung Cancer

7 LUNG CANCER STAGING IASLC Database 100,869 cases treated between ,015 cases suitable for analysis (67,725 NSCLC, 13,290 SCLC, 513 carcinoid tumors) Evidence-based changes in T and M descriptors, maintenance of N descriptors Goldstraw et al. JTO 2007;2: ; multiple articles (Rami-Porta, Rusch, Postmus, Groome, Shepherd, Sculier, Travis) in JTO

8 NUMBERS OF CASES ANALYZED, by type of data source Registry 16,660 Series treated surgically 19,172 Clinical trial 24,239 Series treated by all 7866 modalities (incl surgery) Consortium 5912 Institutional registry 5492 Surgical registry 2154 TOTAL 81,495 Goldstraw et al. JTO 2006;1:

9 Goldstraw et al. JTO 2006;1:

10 Goldstraw et al. JTO 2006;1:

11 Rami-Porta et al. J Thorac Oncol 2007;2:

12 Survival by cn and pn for Surgically Managed Patients Rusch VW et al. J Thorac Oncol, 2007;2:

13 Survival by N Status and Number of Involved N Zones Rusch VW et al. J Thorac Oncol, 2007;2:

14 Goldstraw et al. J Thorac Oncol 2007;2:

15 Overall survival, expressed as a median survival time (MST) and 5-year survival, by clinical stage using the sixth edition of TNM (A) and proposed IASLC recommendations (B). Goldstraw et al. J Thorac Oncol 2007;2:

16 Overall survival, expressed as a median survival time (MST) and 5-year survival, by pathologic stage using sixth edition of TNM (A) and proposed IASLC recommendations (B) Goldstraw et al. J Thorac Oncol 2007; 2:

17 LUNG CANCER STAGING SYSTEM 7 th Edition: 2009 New staging system applies to: Non-small cell lung cancer Small cell lung cancer (replacing limited /extensive staging classification) Carcinoid tumors

18 Naruke vs. Mountain/Dresler Maps Comparison of Nomenclature Japanese Mountain / Dresler (ATS) Level 1 Levels 1 and 2 Levels 2, 3, 4R, 4L Levels 7 and 10 (subcarinal) Levels 4R and 4L Level 7 Rusch VW et al. J Thorac Oncol, 2007;2:

19 New IASLC Lymph Node Map Rusch & Asamura: JTO 2009; 4(5):

20 Developing / Revising Staging Systems Evidence for proposed revisions requires: international & multidisciplinary participation statisticians capable of managing and analyzing huge datasets Prospective data collection key to future revisions for all thoracic malignancies IASLC staging committee will now also address mesothelioma, esophageal Ca and possibly thymoma

21

22 Naruke Lymph Node Map Japan Lung Cancer Society, Tokyo: Kanehara & Co, 2000.

23 Mountain Dresler Lymph Node Map Chest, 1997;111:

Survival analysis of 220 patients with completely resected stage II non small cell lung cancer

Survival analysis of 220 patients with completely resected stage II non small cell lung cancer 窑 Original Article 窑 Chinese Journal of Cancer Survival analysis of 22 patients with completely resected stage II non small cell lung cancer Yun Dai,2,3, Xiao Dong Su,2,3, Hao Long,2,3, Peng Lin,2,3, Jian

More information

Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence

Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence Post- survival in completely resected stage I non-small cell lung cancer with local J-J Hung, 1,2,3 W-H Hsu, 3 C-C Hsieh, 3 B-S Huang, 3 M-H Huang, 3 J-S Liu, 2 Y-C Wu 3 See Editorial, p 185 c A supplementary

More information

Prognostic stratification of patients with T3N1M0 non-small cell lung cancer: which phase should it be?

Prognostic stratification of patients with T3N1M0 non-small cell lung cancer: which phase should it be? DOI 10.1007/s12032-011-9907-y ORIGINAL PAPER Prognostic stratification of patients with T3N1M0 non-small cell lung cancer: which phase should it be? Ali Kilicgun Ozgur Tanriverdi Akif Turna Muzaffer Metin

More information

Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines

Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines April 2008 (presented at 6/12/08 cancer committee meeting) By Shelly Smits, RHIT, CCS, CTR Conclusions by Dr. Ian Thompson, MD Dr. James

More information

Targeted Therapy What the Surgeon Needs to Know

Targeted Therapy What the Surgeon Needs to Know Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures

More information

The current (sixth) TNM Classification of Malignant

The current (sixth) TNM Classification of Malignant IASLC STAGING ARTICLE The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours Peter Goldstraw,

More information

A Practical Guide to Advances in Staging and Treatment of NSCLC

A Practical Guide to Advances in Staging and Treatment of NSCLC A Practical Guide to Advances in Staging and Treatment of NSCLC Robert J. Korst, M.D. Director, Thoracic Surgery Medical Director, The Blumenthal Cancer Center The Valley Hospital Objectives Revised staging

More information

Epidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD

Epidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD Epidemiology, Staging and Treatment of Lung Cancer Mark A. Socinski, MD Associate Professor of Medicine Multidisciplinary Thoracic Oncology Program Lineberger Comprehensive Cancer Center University of

More information

Do we need a revised staging system for malignant pleural mesothelioma? Analysis of the IASLC database

Do we need a revised staging system for malignant pleural mesothelioma? Analysis of the IASLC database Featured Article Do we need a revised staging system for malignant pleural mesothelioma? Analysis of the IASLC database Valerie W. Rusch 1, Dorothy Giroux 2 1 Memorial Sloan-Kettering Cancer Center, New

More information

Travel Distance to Healthcare Centers is Associated with Advanced Colon Cancer at Presentation

Travel Distance to Healthcare Centers is Associated with Advanced Colon Cancer at Presentation Travel Distance to Healthcare Centers is Associated with Advanced Colon Cancer at Presentation Yan Xing, MD, PhD, Ryaz B. Chagpar, MD, MS, Y Nancy You MD, MHSc, Yi Ju Chiang, MSPH, Barry W. Feig, MD, George

More information

Principal Investigator: Valerie W. Rusch, MD, FACS, Chief, Thoracic Surgery Memorial Sloan-Kettering Cancer Center

Principal Investigator: Valerie W. Rusch, MD, FACS, Chief, Thoracic Surgery Memorial Sloan-Kettering Cancer Center Protocol 1101-1088 Phase I study of intra-pleural administration of GL-ONC1 in patients with malignant pleural effusion: primary, metastases and mesothelioma Principal Investigator: Valerie W. Rusch, MD,

More information

Monitoring Clinical Stage to Improve Care

Monitoring Clinical Stage to Improve Care Monitoring Clinical Stage to Improve Care Stephen Dreyer, MD, FACS Cancer Liaison State Chair Nebraska Fremont, NE M. Asa Carter, CTR Manager, Accreditation and Standards American College of Surgeons Chicago,

More information

Mesothelioma. Malignant Pleural Mesothelioma

Mesothelioma. Malignant Pleural Mesothelioma Mesothelioma William G. Richards, PhD Brigham and Women s Hospital Malignant Pleural Mesothelioma 2,000-3,000 cases per year (USA) Increasing incidence Asbestos (50-80%, decreasing) 30-40 year latency

More information

The IASLC Lung Cancer Staging Project

The IASLC Lung Cancer Staging Project IASLC STAGING COMMITTEE ARTICLE A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer Valerie W. Rusch, MD,* Hisao Asamura, MD,

More information

Stage I Non-Small Cell Lung Cancer: Recurrence Patterns, Prognostic Factors and Survival

Stage I Non-Small Cell Lung Cancer: Recurrence Patterns, Prognostic Factors and Survival 16 Stage I Non-Small Cell Lung Cancer: Recurrence Patterns, Prognostic Factors and Survival Jung-Jyh Hung and Yu-Chung Wu Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital

More information

PET/CT in Lung Cancer

PET/CT in Lung Cancer PET/CT in Lung Cancer Rodolfo Núñez Miller, M.D. Nuclear Medicine and Diagnostic Imaging Section Division of Human Health International Atomic Energy Agency Vienna, Austria GLOBOCAN 2012 #1 #3 FDG-PET/CT

More information

UICC World Cancer Congress. Cancer Staging and Quality of Care

UICC World Cancer Congress. Cancer Staging and Quality of Care UICC World Cancer Congress August 27 30, 2012, Montreal CANCER STAGE: A neglected cornerstone of Cancer Control Cancer Staging and Quality of Care Christian Wittekind Institut für Pathologie UKL 1 Agenda!

More information

TNM Classification for Lung Cancer

TNM Classification for Lung Cancer Review TNM Classification for Lung Cancer Yoh Watanabe, MD 1,2,3 The international tumor-node-metastasis (TNM) staging system is the international language in cancer diagnosis and treatment. Six revisions

More information

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012 Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro Joon H. Lee 9/17/2012 Malignant Pleural Mesothelioma (Epidemiology) Incidence: 7/mil (Japan) to 40/mil (Australia) Attributed secondary to asbestos

More information

Stage IIIB disease includes patients with T4 tumors,

Stage IIIB disease includes patients with T4 tumors, Guidelines on Treatment of Stage IIIB Non-small Cell Lung Cancer* James R. Jett, MD, FCCP; Walter J. Scott, MD, FCCP; M. Patricia Rivera MD, FCCP; and William T. Sause, MD, FACR Stage IIIB includes patients

More information

Proposed Adjustments to Pathologic Staging of Epithelial Malignant Pleural Mesothelioma Based on Analysis of 354 Cases

Proposed Adjustments to Pathologic Staging of Epithelial Malignant Pleural Mesothelioma Based on Analysis of 354 Cases Original Article Proposed Adjustments to Pathologic Staging of Epithelial Malignant Pleural Mesothelioma Based on Analysis of 354 Cases William G. Richards, PhD 1,2 ; John J. Godleski, MD 2,3 ; Beow Y.

More information

Investigating mediastinal lymph node stations segmentation on thoracic CT following experts guidelines

Investigating mediastinal lymph node stations segmentation on thoracic CT following experts guidelines Investigating mediastinal lymph node stations segmentation on thoracic CT following experts guidelines D. Sarrut 1,2, L. Claude 2, S. Rit 1,2, R. Pinho 1,2, G. Pitson 3, R. Lynch 3 (1) Université de Lyon,

More information

Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008

Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008 Special Report Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008 Matthew B. Schabath, PhD, Zachary J. Thompson, PhD,

More information

Lung Cancer Treatment Guidelines

Lung Cancer Treatment Guidelines Updated June 2014 Derived and updated by consensus of members of the Providence Thoracic Oncology Program with the aid of evidence-based National Comprehensive Cancer Network (NCCN) national guidelines,

More information

EMR Can anyone do this?

EMR Can anyone do this? EMR Can anyone do this? Norio Fukami, MD University of Colorado Piecemeal resection? 1 Endoscopic mucosal resection (EMR) and Endoscopic submucosal dissection (ESD) Endoscopic removal of premalignant or

More information

Lung Cancer and Mesothelioma

Lung Cancer and Mesothelioma Lung Cancer and Mesothelioma Robert Kratzke, M.D. John C. Skoglund Professor of Lung Cancer Research Section of Heme/Onc/Transplant Department of Medicine University of Minnesota Medical School Malignant

More information

Malignant Mesothelioma Current Approaches to a Difficult Problem. Raja M Flores, MD Thoracic Surgery Memorial Sloan-Kettering Cancer Center

Malignant Mesothelioma Current Approaches to a Difficult Problem. Raja M Flores, MD Thoracic Surgery Memorial Sloan-Kettering Cancer Center Malignant Mesothelioma Current Approaches to a Difficult Problem Raja M Flores, MD Thoracic Surgery Memorial Sloan-Kettering Cancer Center Malignant Pleural Mesothelioma Clinical Presentation Insidious

More information

Table of Contents. Data Supplement 1: Summary of ASTRO Guideline Statements. Data Supplement 2: Definition of Terms

Table of Contents. Data Supplement 1: Summary of ASTRO Guideline Statements. Data Supplement 2: Definition of Terms Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation

More information

Radiation Therapy in the Treatment of

Radiation Therapy in the Treatment of Lung Cancer Radiation Therapy in the Treatment of Lung Cancer JMAJ 46(12): 537 541, 2003 Kazushige HAYAKAWA Professor and Chairman, Department of Radiology, Kitasato University School of Medicine Abstract:

More information

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project Data Forms and Fields in CRAB Electronic Data Capture System - Reduced Set - Pivotal data elements for developing

More information

2009 Cancer Committee

2009 Cancer Committee 2009 Cancer Committee Lung (non-small cell) Cancer Study Stage IIIA and IIIB John Clouse, M.D. Alicia Stark, RHIT Jeff Robinson Table of Cont ent s Table of Contents... 1 Lung (non-small cell) Cancer Facts.2

More information

Chapter 2 Staging of Breast Cancer

Chapter 2 Staging of Breast Cancer Chapter 2 Staging of Breast Cancer Zeynep Ozsaran and Senem Demirci Alanyalı 2.1 Introduction Five decades ago, Denoix et al. proposed classification system (tumor node metastasis [TNM]) based on the dissemination

More information

SMALL. 1-800-298-2436 LungCancerAlliance.org

SMALL. 1-800-298-2436 LungCancerAlliance.org Understanding series SMALL CELL LUNG CANCER 1-800-298-2436 LungCancerAlliance.org A guide for the patient I TABLE OF CONTENTS ANATOMY OF THE LUNGS The following image shows different parts that make up

More information

Although many reports on the prognostic factors of non small cell

Although many reports on the prognostic factors of non small cell Carbone et al T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non small cell lung cancer Emanuela Carbone, MD a,b Hisao Asamura, MD a Hidefumi Takei, MD a Haruhiko Kondo, MD

More information

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the

More information

Probe: Could you tell me about when?

Probe: Could you tell me about when? PERIODIC ASSESSMENT OF TREATMENT AND VITAL/DISEASE STATUS Periodic Assessment of Cancer Treatment and Disease Status (To be administered to patient at 3 months and reviewed at 6, 9 and 12 months) Instructions:

More information

Small Cell Lung Cancer

Small Cell Lung Cancer Small Cell Lung Cancer Types of Lung Cancer Non-small cell carcinoma (NSCC) (87%) Adenocarcinoma (38%) Squamous cell (20%) Large cell (5%) Small cell carcinoma (13%) Small cell lung cancer is virtually

More information

Diagnóstico y Terapias Locales

Diagnóstico y Terapias Locales Diagnóstico y Terapias Locales Dra Marga Majem Hospital de la Santa Creu i Sant Pau AGENDA Revised (8th) Edition of TNM Staging System for Lung Cancer Surgical Approaches in Localized Lung Cancer Radiation

More information

Lung Cancer Staging: Clinical and Radiologic Perspectives

Lung Cancer Staging: Clinical and Radiologic Perspectives 99 Lung Cancer Staging: Clinical and Radiologic Perspectives Sophie Chheang, MD 1 Kathleen Brown, MD 2 1 Division of Interventional Radiology, Department of Radiology, Weill Cornell Medical College, New

More information

The National Clinical Lung Cancer Audit (LUCADA)

The National Clinical Lung Cancer Audit (LUCADA) The National Clinical Lung Cancer Audit (LUCADA) DATA MANUAL Title: Version: 3.1.5 Date: September 2013 LUCADA Lung Cancer Audit VERSION HISTORY Version Date Issued Brief Summary of Change Owner s Name

More information

New Trends & Current Research in the Treatment of Lung Cancer, Pt. II

New Trends & Current Research in the Treatment of Lung Cancer, Pt. II New Trends & Current esearch in the Treatment of Lung Cancer, Pt. II Howard (Jack) West, MD President & CEO, GACE Medical Director, Thoracic Oncology Program Swedish Cancer Institute Seattle, WA Cancer

More information

Cancer of the Cardia/GE Junction: Surgical Options

Cancer of the Cardia/GE Junction: Surgical Options Cancer of the Cardia/GE Junction: Surgical Options Michael A Smith, MD Associate Chief Thoracic Surgery Center for Thoracic Disease St Joseph s Hospital and Medical Center Phoenix, AZ Michael Smith, MD

More information

Facing Lung Cancer? Learn why da Vinci Surgery may be your best treatment option for lung cancer.

Facing Lung Cancer? Learn why da Vinci Surgery may be your best treatment option for lung cancer. Facing Lung Cancer? Learn why da Vinci Surgery may be your best treatment option for lung cancer. The Condition: Lung Cancer The lung is the organ that moves oxygen through your body. You have two lungs

More information

Surgical therapy of. who should be operated

Surgical therapy of. who should be operated SAMO Interdisciplinary Workshop on Chest Tumors Lucerne, 13th and 14th January 2012 Surgical therapy of mesothelioma, who should be operated Walter Weder MD Professor of Surgery University Hospital Zurich

More information

CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy

CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy Joseph M. Tuscano, Jason Kato, David Pearson, Chengyi Xiong, Laura Newell, Yunpeng Ma, David R. Gandara,

More information

SMALL CELL LUNG CANCER

SMALL CELL LUNG CANCER Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New

More information

Pathology of lung cancer

Pathology of lung cancer Pathology of lung cancer EASO COURSE ON LUNG CANCER AND MESOTHELIOMA DAMASCUS (SYRIA), MAY 3-4, 2007 Gérard ABADJIAN MD Pathologist Associate Professor, Saint Joseph University Pathology Dept. Hôtel-Dieu

More information

Lung Cancer. Public Outcomes Report. Submitted by Omar A. Majid, MD

Lung Cancer. Public Outcomes Report. Submitted by Omar A. Majid, MD Public Outcomes Report Lung Cancer Submitted by Omar A. Majid, MD Lung cancer is the most common cancer-related cause of death among men and women. It has been estimated that there will be 226,1 new cases

More information

The Ontario Cancer Registry moves to the 21 st Century

The Ontario Cancer Registry moves to the 21 st Century The Ontario Cancer Registry moves to the 21 st Century Rebuilding the OCR Public Health Ontario Grand Rounds Oct. 14, 2014 Diane Nishri, MSc Mary Jane King, MPH, CTR Outline 1. What is the Ontario Cancer

More information

Characterization of lung cancer patients, their actual treatment and survival: experience in Slovenia

Characterization of lung cancer patients, their actual treatment and survival: experience in Slovenia Characterization of lung cancer patients, their actual treatment and survival: experience in Slovenia Lučka Debevec 1, Andrej Debeljak 1, Janez Eržen 2, Viljem Kovač 3, Izidor Kern 1 1 University Clinic

More information

Computed tomographic atlas for the new international lymph node map for lung cancer: A radiation oncologist perspective

Computed tomographic atlas for the new international lymph node map for lung cancer: A radiation oncologist perspective Practical Radiation Oncology (2013) 3, 54 66 www.practicalradonc.org Special Article Computed tomographic atlas for the new international lymph node map for lung cancer: A radiation oncologist perspective

More information

How To Treat Lung Cancer At Cleveland Clinic

How To Treat Lung Cancer At Cleveland Clinic Treatment Guide Lung Cancer Management The Chest Cancer Center at Cleveland Clinic, which includes specialists from the Respiratory Institute, Taussig Cancer Institute and Miller Family Heart & Vascular

More information

DELRAY MEDICAL CENTER. Cancer Program Annual Report

DELRAY MEDICAL CENTER. Cancer Program Annual Report DELRAY MEDICAL CENTER Cancer Program Annual Report Cancer Statistical Data From 2010 TABLE OF CONTENTS Chairman s Report....3 Tumor Registry Statistical Report Summary...4-11 Lung Study.12-17 Definitions

More information

Report with statistical data from 2007

Report with statistical data from 2007 2008 Cancer Program Annual Report with statistical data from 2007 Lake Cumberland Regional Hospital 305 Langdon Streett Somerset, KY 42503 Telephone: 606-679-7441 Fax: 606-678-9919 Cancer Committee Mullai,

More information

Treatment & Research. Treatment & Research

Treatment & Research. Treatment & Research Treatment & Research In March 1990, I became ill while on a trip to Thailand. I was examined and tested and given instructions to go to the emergency room when I arrived at home. In Great Falls, I learned

More information

Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data

Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data The 2014 Cancer Program Annual Public Reporting of Outcomes/Annual Site Analysis Statistical Data from 2013 More than 70 percent of all newly diagnosed cancer patients are treated in the more than 1,500

More information

The lungs What is lung cancer? How common is it? Risks & symptoms Diagnosis & treatment options

The lungs What is lung cancer? How common is it? Risks & symptoms Diagnosis & treatment options Why We re Here The lungs What is lung cancer? How common is it? Risks & symptoms Diagnosis & treatment options What Are Lungs? What Do They Do? 1 Located in the chest Allow you to breathe Provide oxygen

More information

Recommendations for the Reporting of Pleural Mesothelioma

Recommendations for the Reporting of Pleural Mesothelioma Recommendations for the Reporting of Pleural Mesothelioma Association of Directors of Anatomic and Surgical Pathology * DOI: 10.1309/6A30YQHBMTHEJTEM It has been evident for decades that pathology reports

More information

The Need for Accurate Lung Cancer Staging

The Need for Accurate Lung Cancer Staging The Need for Accurate Lung Cancer Staging Peter Baik, DO Thoracic Surgery Cancer Treatment Centers of America Oklahoma Osteopathic Association 115th Annual Convention Financial Disclosures: None 2 Objectives

More information

Understanding Your Surgical Options for Lung Cancer

Understanding Your Surgical Options for Lung Cancer Information Booklet for Patients Understanding Your Surgical Options for Lung Cancer Understanding Lung Cancer If you have just been diagnosed with lung cancer, this booklet will serve as an informational

More information

CANCER PULMON: ESTADIOS INICIALES POSTMUNDIAL PULMON DENVER 2015. 8-10-2015.Manuel Cobo Dols S. Oncología Médica HU Málaga Regional y VV

CANCER PULMON: ESTADIOS INICIALES POSTMUNDIAL PULMON DENVER 2015. 8-10-2015.Manuel Cobo Dols S. Oncología Médica HU Málaga Regional y VV CANCER PULMON: ESTADIOS INICIALES POSTMUNDIAL PULMON DENVER 2015 8-10-2015.Manuel Cobo Dols S. Oncología Médica HU Málaga Regional y VV Meta-analisis LACE: adyuvancia vs no adyuvancia Pignon JP, et al.

More information

Advances in Lung Cancer: A Multidisciplinary Approach

Advances in Lung Cancer: A Multidisciplinary Approach Advances in Lung Cancer: A Multidisciplinary Approach Saturday, April 25, 2015 127 Public Square Cleveland, Ohio Learning Objectives About the Course This one-day course will provide a topical, clinically

More information

Protocol for the Examination of Specimens From Patients With Malignant Pleural Mesothelioma

Protocol for the Examination of Specimens From Patients With Malignant Pleural Mesothelioma Protocol for the Examination of Specimens From Patients With Malignant Pleural Mesothelioma Based on AJCC/UICC TNM, 7th edition Protocol web posting date: February 1, 2011 Procedures Resection Authors

More information

ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C

ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC Thursday 16th April 2015 13:10 14:20 Room C 1 Contents Programme.... 2 Welcome message.... 3 Faculty biographies.... 4 Symposium

More information

Lung Cancer Workup and Staging

Lung Cancer Workup and Staging CHAPTER 16 Lung Cancer Workup and Staging Bernard J. Park and Valerie W. Rusch The Staging System Diagnosis and Staging History and Physical Examination Noninvasive Modalities Chest Radiography Sputum

More information

Update on Mesothelioma

Update on Mesothelioma November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical

More information

Lymph Nodes and Cancer What is the lymph system?

Lymph Nodes and Cancer What is the lymph system? Lymph Nodes and Cancer What is the lymph system? Our bodies have a network of lymph vessels and lymph nodes. (Lymph is pronounced limf.) This network is a part of the body s immune system. It collects

More information

Thoracic 18F-FDG PETCT

Thoracic 18F-FDG PETCT Thoracic 18F-FDG PETCT RAD Magazine, 41, 482, 13-16 Dr Allanah arker Specialist registrar radiology Dr Nagmi Qureshi Consultant cardiothoracic radiologist Papworth Hospital, Cambridge email: allanahbarker@nhs.net

More information

PET. Can we afford PET-CT. Positron annihilation. PET-CT scanner. PET detection

PET. Can we afford PET-CT. Positron annihilation. PET-CT scanner. PET detection PET-CT Can we afford PET-CT John Buscombe New technology Combines functional information-pet anatomical information-ct Machine able to perform both studies in single imaging episode PET imaging depends

More information

CHAPTER 6: TREATMENT FOR SMALL CELL LUNG CANCER

CHAPTER 6: TREATMENT FOR SMALL CELL LUNG CANCER CHAPTER 6: TREATMENT FOR SMALL CELL LUNG CANCER INTRODUCTION This chapter provides an overview of treatment for small cell lung cancer (SCLC). Treatment options are presented based on the extent of disease.

More information

Crosswalk for Positron Emission Tomography (PET) Imaging Codes G0230 G0030, G0032, G0034, G0036, G0038, G0040, G0042, G0044, G0046

Crosswalk for Positron Emission Tomography (PET) Imaging Codes G0230 G0030, G0032, G0034, G0036, G0038, G0040, G0042, G0044, G0046 Positron Emission Tomography (PET) CPT to HCPCS Level Crosswalk Changes below from CMS Change Request 3741 Transmittals 518 & 31 published on April 1, 2005; mplementation of CPT codes are effective January

More information

An Overview of Lung Cancer Symptoms, Pathophysiology, And Treatment Linda H. Yoder

An Overview of Lung Cancer Symptoms, Pathophysiology, And Treatment Linda H. Yoder CE Objectives and Evaluation Form appear on page 235. An Overview of Lung Cancer Symptoms, Pathophysiology, And Treatment Linda H. Yoder Patients with lung cancer can provide treatment challenges for even

More information

British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015

British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015 0116 250 2811 dawn.mckinley@uhl-tr.nhs.uk www.btog.org @BTOGORG British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015 BTOG s Aim BTOG is the multi-disciplinary group for professionals

More information

Protein kinase C alpha expression and resistance to neo-adjuvant gemcitabine-containing chemotherapy in non-small cell lung cancer

Protein kinase C alpha expression and resistance to neo-adjuvant gemcitabine-containing chemotherapy in non-small cell lung cancer Protein kinase C alpha expression and resistance to neo-adjuvant gemcitabine-containing chemotherapy in non-small cell lung cancer Dan Vogl Lay Abstract Early stage non-small cell lung cancer can be cured

More information

Treatment Algorithms for the Management of Lung Cancer in NSW Guide for Clinicians

Treatment Algorithms for the Management of Lung Cancer in NSW Guide for Clinicians Treatment Algorithms for the Management of Lung Cancer in NSW Guide for Clinicians Background The Cancer Institute New South Wales Oncology Group Lung (NSWOG Lung) identified the need for the development

More information

Malignant pleural mesothelioma P/D vs. EPP

Malignant pleural mesothelioma P/D vs. EPP 3 rd International Thoracic Oncology Congress Dresden, September 13 15, 2012 Malignant pleural mesothelioma P/D vs. EPP Walter Weder, MD Professor of Surgery Dokumentenname Datum Seite 1 Extrapleural Pneumonectomy

More information

How To Know When To Stage Lung Cancer

How To Know When To Stage Lung Cancer WHITE PAPER - SBRT for Non Small Cell Lung Cancer I. Introduction This white paper will focus on non-small cell lung carcinoma with sections one though six comprising a general review of lung cancer from

More information

How To Compare The Effects Of A Hysterectomy And A Hysterectomy

How To Compare The Effects Of A Hysterectomy And A Hysterectomy A RANDOMIZED TRIAL COMPARING RADICAL HYSTERECTOMY AND PELVIC NODE DISSECTION VS SIMPLE HYSTERECTOMY AND PELVIC NODE DISSECTION IN PATIENTS WITH LOW RISK EARLY STAGE CERVICAL CANCER A Gynecologic Cancer

More information

Program Chairs: Robert W. Holloway, MD and Martin Martino, MD Speakers and times are subject to change

Program Chairs: Robert W. Holloway, MD and Martin Martino, MD Speakers and times are subject to change FRIDAY, FEBRUARY 20, 2015 Program Chairs: and Martin Martino, MD Speakers and times are subject to change 6:00 a.m. 6:00 p.m. Registration/Information Desk /L Foyer 6:00 a.m. 6:00 p.m. Speaker Ready Area

More information

ST JOSEPH REGIONAL HEALTH CENTER LUNG CANCER ANALYSIS Incidence, Diagnosis, Treatment and Survival

ST JOSEPH REGIONAL HEALTH CENTER LUNG CANCER ANALYSIS Incidence, Diagnosis, Treatment and Survival ST JOSEPH REGIONAL HEALTH CENTER LUNG CANCER ANALYSIS Incidence, Diagnosis, Treatment and Survival It is logical that the Cancer Program Committee choose to review the Lung Site, as Lung is the second

More information

Report series: General cancer information

Report series: General cancer information Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for

More information

Adjuvant Therapy Non Small Cell Lung Cancer. Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015

Adjuvant Therapy Non Small Cell Lung Cancer. Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015 Adjuvant Therapy Non Small Cell Lung Cancer Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015 No Disclosures Number of studies Studies Per Month 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3

More information

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D. Breast Cancer: from bedside and grossing room to diagnoses and beyond Adriana Corben, M.D. About breast anatomy Breasts are special organs that develop in women during puberty when female hormones are

More information

Round Table with Drs. Anne Tsao and Alex Farivar, Case 2: Mesothelioma

Round Table with Drs. Anne Tsao and Alex Farivar, Case 2: Mesothelioma Round Table with Drs. Anne Tsao and Alex Farivar, Case 2: Mesothelioma I d like to welcome everyone, thanks for coming out to our lunch with experts. The faculty today are great people in the thoracic

More information

Lung Cancer and Pleural Mesothelioma: Cleveland Clinic Multidisciplinary Approaches to Care

Lung Cancer and Pleural Mesothelioma: Cleveland Clinic Multidisciplinary Approaches to Care Lung Cancer and Pleural Mesothelioma: Cleveland Clinic Multidisciplinary Approaches to Care Saturday, April 27, 2013 Cleveland Marriott Downtown at Key Center 127 Public Square Cleveland, Ohio Learning

More information

Screening, early referral and treatment for asbestos related cancer

Screening, early referral and treatment for asbestos related cancer Screening, early referral and treatment for asbestos related cancer Marc de Perrot, MD, MSc, FRCSC Toronto Mesothelioma Research Program University of Toronto Asbestos related diseases Mesothelioma Lung

More information

TRATTAMENTO COMBINATO RADIO- CHEMIOTERAPICO NEL III STADIO NSCLC

TRATTAMENTO COMBINATO RADIO- CHEMIOTERAPICO NEL III STADIO NSCLC TRATTAMENTO COMBINATO RADIO- CHEMIOTERAPICO NEL III STADIO NSCLC Dr.ssa Sara Ramella Radioterapia Oncologica Campus Bio-Medico Trimodality therapy offers a promising chance of long-term survival Evidenze

More information

Malignant pleural mesothelioma (MPM) is an uncommon

Malignant pleural mesothelioma (MPM) is an uncommon ORIGINAL ARTICLE Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database Valerie W. Rusch, MD,* Dorothy Giroux, Catherine Kennedy, Enrico Ruffini, Ayten K.

More information

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); as04@aub.edu.lb Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT

More information

Particle Therapy for Lung Cancer. Bradford Hoppe MD, MPH Assistant Professor University of Florida bhoppe@floridaproton.org

Particle Therapy for Lung Cancer. Bradford Hoppe MD, MPH Assistant Professor University of Florida bhoppe@floridaproton.org Particle Therapy for Lung Cancer Bradford Hoppe MD, MPH Assistant Professor University of Florida bhoppe@floridaproton.org Content Rationale for Particle Therapy in Lung Cancer Proof of Principle Treatment

More information

SMALL. 1-800-298-2436 LungCancerAlliance.org

SMALL. 1-800-298-2436 LungCancerAlliance.org UNDERSTANDING Non- SMALL CELL LUNG CANCER 1-800-298-2436 LungCancerAlliance.org A guide for the patient I ANATOMY OF THE LUNGS The following image shows different parts that make up the lungs. Please use

More information

SAKK Lung Cancer Group. Current activities and future projects

SAKK Lung Cancer Group. Current activities and future projects SAKK Lung Cancer Group Current activities and future projects SAKK Lung Cancer Group Open group of physicians interested in lung cancer Mostly Medical Oncologists, but also Thoracic Surgeons Radiation

More information

Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy

Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy W. Fraser Symmans, M.D. Associate Professor of Pathology UT M.D. Anderson Cancer Center Pathologic Complete Response (pcr) Proof

More information

Current Status and Perspectives of Radiation Therapy for Breast Cancer

Current Status and Perspectives of Radiation Therapy for Breast Cancer Breast Cancer Current Status and Perspectives of Radiation Therapy for Breast Cancer JMAJ 45(10): 434 439, 2002 Masahiro HIRAOKA, Masaki KOKUBO, Chikako YAMAMOTO and Michihide MITSUMORI Department of Therapeutic

More information

Definitive Treatment of Poor-Risk Patients with Stage I Lung Cancer. A Single Institution Experience

Definitive Treatment of Poor-Risk Patients with Stage I Lung Cancer. A Single Institution Experience ORIGINAL ARTICLE Definitive Treatment of Poor-Risk Patients with Stage I Lung Cancer A Single Institution Experience Michael Hsie, MD,* Stefania Morbidini-Gaffney, MD,* Leslie J. Kohman, MD, Elisabeth

More information

9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH

9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH 9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH Differentiated thyroid cancer expresses the TSH receptor on the cell membrane and responds to TSH stimulation by increasing

More information

AJCC Cancer Staging System, 8 th Edition: UPDATE

AJCC Cancer Staging System, 8 th Edition: UPDATE AJCC Cancer Staging System, 8 th Edition: UPDATE Creating the Bridge from a Population Based to a More Personalized Approach Mahul B. Amin, MD, FCAP Editor-in-Chief, AJCC Cancer Staging System Validating

More information

Lung Cancer: An Overview

Lung Cancer: An Overview VOL. I Issue 2 2010 Lung Cancer: An Overview By Matthew F. Koscielski, M.D. Lung cancer is the most common cause of cancer mortality worldwide. In the United States there are about 220,000 new cases of

More information

Male. Female. Death rates from lung cancer in USA

Male. Female. Death rates from lung cancer in USA Male Female Death rates from lung cancer in USA Smoking represents an interesting combination of an entrenched industry and a clearly drug-induced cancer Tobacco Use in the US, 1900-2000 5000 100 Per Capita

More information